Plerixafor Metrixafor 24mg Injection

24mg Injection in 1 Vial

4.5 (154)

₹9,000

Metrixafor 24mg Injection is used in autologous stem cell transplant procedures, helping mobilize blood-forming stem cells from the bone marrow into the bloodstream so they can be collected for transplant after chemotherapy or radiation treatment in cancer patients. Administered by a qualified medical professional, it should be taken exactly as prescribed, with treatment continuing as advised by your doctor.

Description

Introduction Of Metrixafor 24mg Injection:

Metrixafor 24mg Injection contains Plerixafor, a hematopoietic stem cell mobilizer used, in combination with filgrastim (G-CSF), to help release stem cells from the bone marrow into the bloodstream in patients with non-Hodgkin’s lymphoma and multiple myeloma undergoing autologous stem cell transplantation.

Metrixafor 24mg Injection is administered only by a trained healthcare professional as a subcutaneous injection, approximately 11 hours before the start of apheresis (stem cell collection), following an initial course of G-CSF. Your doctor will decide the dose and duration of use based on your body weight, condition, and treatment plan. It should never be self-administered without medical supervision.

Diarrhea, nausea, and injection site reactions are among the most common effects of this medicine. Your doctor may advise regular blood tests to monitor your white blood cell and platelet counts during treatment. Inform your doctor immediately if you notice difficulty breathing, swelling of the face or throat, severe abdominal pain, or unusual bleeding.

Uses Of Metrixafor 24mg Injection:

  • Stem cell mobilization in Non-Hodgkin’s Lymphoma
  • Stem cell mobilization in Multiple Myeloma

Benefits Of Metrixafor 24mg Injection:

1. Non-Hodgkin’s Lymphoma

In patients with non-Hodgkin’s lymphoma preparing for autologous stem cell transplantation, Metrixafor 24mg Injection helps mobilize a sufficient number of stem cells from the bone marrow into the blood, supporting successful collection and later engraftment after transplant.

2. Multiple Myeloma

Multiple myeloma is a cancer of plasma cells in the bone marrow. Metrixafor 24mg Injection, used together with G-CSF, helps improve the number of stem cells collected for transplantation, supporting better outcomes during the transplant process.

Side effects of Metrixafor 24mg Injection:

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.

Common side effects of Plerixafor:

  • Diarrhea
  • Nausea
  • Vomiting
  • Constipation
  • Dry mouth
  • Injection site reactions
  • Dizziness
  • Fatigue

Mechanism Of Action Of Metrixafor 24mg Injection:

Metrixafor Injection contains Plerixafor, a CXCR4 chemokine receptor antagonist. It works by blocking the CXCR4 receptor on stem cells, which normally helps keep them anchored within the bone marrow. By interrupting this signal, Metrixafor allows stem cells to be released into the bloodstream, where they can be collected for transplantation.

Contact Us

Info Table
Strength 20 mg/ml
Brand Metrixafor 24mg
Form Injection
Pack Size 1.2ml
Manufacturer METTA LIFE SCIENCES PRIVATE LIMITED
Packaging Type Box
Composition PLERIXAFOR – (24mg)
Treatment Autologous undeveloped cell relocate
Country of Origin Made in India
Vendor Info
Benefits
Reviews

Description

Introduction Of Metrixafor 24mg Injection:

Metrixafor 24mg Injection contains Plerixafor, a hematopoietic stem cell mobilizer used, in combination with filgrastim (G-CSF), to help release stem cells from the bone marrow into the bloodstream in patients with non-Hodgkin’s lymphoma and multiple myeloma undergoing autologous stem cell transplantation.

Metrixafor 24mg Injection is administered only by a trained healthcare professional as a subcutaneous injection, approximately 11 hours before the start of apheresis (stem cell collection), following an initial course of G-CSF. Your doctor will decide the dose and duration of use based on your body weight, condition, and treatment plan. It should never be self-administered without medical supervision.

Diarrhea, nausea, and injection site reactions are among the most common effects of this medicine. Your doctor may advise regular blood tests to monitor your white blood cell and platelet counts during treatment. Inform your doctor immediately if you notice difficulty breathing, swelling of the face or throat, severe abdominal pain, or unusual bleeding.

Uses Of Metrixafor 24mg Injection:

  • Stem cell mobilization in Non-Hodgkin’s Lymphoma
  • Stem cell mobilization in Multiple Myeloma

Benefits Of Metrixafor 24mg Injection:

1. Non-Hodgkin’s Lymphoma

In patients with non-Hodgkin’s lymphoma preparing for autologous stem cell transplantation, Metrixafor 24mg Injection helps mobilize a sufficient number of stem cells from the bone marrow into the blood, supporting successful collection and later engraftment after transplant.

2. Multiple Myeloma

Multiple myeloma is a cancer of plasma cells in the bone marrow. Metrixafor 24mg Injection, used together with G-CSF, helps improve the number of stem cells collected for transplantation, supporting better outcomes during the transplant process.

Side effects of Metrixafor 24mg Injection:

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.

Common side effects of Plerixafor:

  • Diarrhea
  • Nausea
  • Vomiting
  • Constipation
  • Dry mouth
  • Injection site reactions
  • Dizziness
  • Fatigue

Mechanism Of Action Of Metrixafor 24mg Injection:

Metrixafor Injection contains Plerixafor, a CXCR4 chemokine receptor antagonist. It works by blocking the CXCR4 receptor on stem cells, which normally helps keep them anchored within the bone marrow. By interrupting this signal, Metrixafor allows stem cells to be released into the bloodstream, where they can be collected for transplantation.

Contact Us

Reviews

There are no reviews yet.

Be the first to review “Plerixafor Metrixafor 24mg Injection”

Your email address will not be published. Required fields are marked *

Frequently Asked Questions

From sourcing to delivery, we ensure reliability at every step. Our operations follow strict quality and regulatory standards.

What is Metrixafor 24mg Injection used for?
Metrixafor Injection (Plerixafor) is a hematopoietic stem cell mobilizer used to prepare patients for autologous stem cell transplantation.
It helps move stem cells from the bone marrow into the bloodstream, where they can be collected for transplantation after chemotherapy or radiation therapy.
It’s given as an injection by a qualified healthcare professional, with the dose and frequency determined by your doctor based on your treatment needs.
It’s a procedure where a patient’s own blood-forming stem cells are collected, and later returned to the body after chemotherapy or radiation treatment for certain cancers.
It’s manufactured by Metta Life Sciences Private Limited in India and contains Plerixafor, supplied as a 1.2ml vial.
It works by blocking a receptor that keeps stem cells anchored in the bone marrow, releasing them into the bloodstream so they can be collected for stem cell transplant procedures. See Drugs.com for more.

Related products